FindMyKOL

Nina Sundaram, MD

Basic profile

Icahn School of Medicine at Mount Sinai

ORCIDNone on fileNPI↗
✓ Itemized record
RegionNew York, NY · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLFindMyKOL type: RegionalLatest publication2015Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nina Sundaram is an Endocrinology/Metabolic physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 10 publications with 230 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Publications indexed by OpenAlex. Counts exclude supporting files.

230citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    59.7%
    GLP-1 receptor agonist23.8%
    Ozempic44%Mounjaro43%Trulicity13%
    Part D≥23 patients
    Biguanide (metformin)21.4%
    Metformin Hcl Er86%Metformin Hcl14%
    Part D≥63 patients

    + 4 more classes in this area

  • Hormonal (systemic)

    23.9%
    l-Thyroxine20.8%
    Synthroid53%Levothyroxine Sodium47%
    Part D≥33 patients
    l-Triiodothyronine3.1%
    Liothyronine Sodium100%
    Part D≥14 patients
  • Cardiovascular

    12.7%
    Statin7.5%
    Rosuvastatin Calcium55%Atorvastatin Calcium45%
    Part D≥16 patients
    Cholesterol absorption inhibitor2%
    Ezetimibe100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”